Investors Take Action: Lead the uniQure N.V. Securities Fraud Lawsuit Today

Investors in uniQure N.V. (NASDAQ: QURE) are being called to action by the Schall Law Firm, a national firm specializing in the rights of shareholders, as they announce a class action lawsuit against the company. This suit has emerged in the wake of significant allegations concerning violations related to the Securities Exchange Act of 1934.

The class action lawsuit primarily targets investors who purchased securities from uniQure during the fixed period between September 24, 2025, and October 31, 2025. If you are among those who faced financial losses during this period, you are encouraged to reach out to the Schall Law Firm before the deadline on April 13, 2026, to explore your legal options and potentially join the case.

The Allegations

According to the accusations outlined in the complaint, uniQure made a series of misleading statements that affected market perceptions and investor decisions. Notably, the company failed to achieve full FDA approval for its pivotal study, an important step that investors believed was achievable. Furthermore, the allegations claim that uniQure misrepresented the status of its Biologics License Application (BLA) by suggesting it would not face delays in supporting its submitted data to the FDA.

These misleading communications, the lawsuit asserts, led to a material misrepresentation concerning the company's standing and future potential. As a result of the damaging information coming to light, investors encountered substantial losses when the company's real situation became evident, leading to a fall in stock prices.

Joining the Class Action

Investors who purchased uniQure stocks during the specified class period are urged to act swiftly. By participating in this lawsuit, shareholders may have the opportunity to recover their financial losses and seek justice against any perceived wrongdoing by the company.

Brian Schall, one of the firm's representatives, indicates that reaching out for a consultation is completely free of charge. Individuals interested in discussing their rights and obtaining more information can contact the Schall Law Firm directly at their Los Angeles office or through their website.

It is critical to note that the class action lawsuit has not yet been certified. Until certification, any potential participants remain unrepresented by counsel, highlighting the importance of taking timely action if you are affected.

Conclusion

This lawsuit presents a significant avenue for investors of uniQure N.V. who feel wronged or misled. The Schall Law Firm stands ready to represent those interested in addressing their grievances regarding possible misconduct. This legal action serves as a reminder of the importance of transparency and integrity in the financial markets, as well as the role of shareholder rights in holding companies accountable.

For any investors looking to reclaim losses and ensure their rights are defended, now is the time to act. Explore your options, as waiting too long may result in missing out on the opportunity to recover lost funds during this tumultuous period.